Search Tag: terminal diseases

Executive Health Management

Immunicom-appoints-dr-annette-marleau-as-chief-technology-officer

2022 17 Feb

Dr. Marleau will direct the Company’s R&D efforts and advance its pipeline of subtractive therapies treating cancer and other terminal diseases Immunicom, Inc., a clinical-stage biotechnology company pioneering subtractive therapies to treat unmet medical needs in cancer and other terminal diseases, announced that Dr. Annette Marleau is assuming...Read more